About Us
Advancing the Future of Intelligent Biosensing
iCGM Technologies LLC is a medical technology R&D company dedicated to developing next-generation implantable biosensor platforms and AI-driven health analytics that transform how biometric data is captured, analyzed, and applied in clinical care.
Our Mission
Making Continuous Biometric Intelligence Accessible
Our mission is to design, develop, and commercialize minimally invasive implantable biosensor technologies that deliver continuous, clinical-grade biometric data to patients, clinicians, and healthcare systems — enabling earlier intervention, better outcomes, and a new standard of personalized care. We are committed to responsible innovation, rigorous science, and building technologies that are safe, accurate, and transformative.
Scientific Rigor
Every technology we develop is grounded in rigorous science, validated engineering, and evidence-based design principles.
Patient-Centered Design
We design for the patient first — prioritizing safety, comfort, and clinical utility in every product decision.
Responsible Innovation
We pursue innovation with integrity, maintaining transparency with regulators, partners, and the healthcare community.
Collaborative Approach
We believe the best medical technologies are built through collaboration — with clinicians, researchers, and industry partners.
Leadership
Fatima Ogoy Calica
President, Founder & Inventor — iCGM Technologies LLC
Fatima Ogoy Calica is the President, Founder, and Inventor of iCGM Technologies LLC. She founded the company with a singular vision: to bring next-generation implantable biosensing solutions to patients and healthcare systems worldwide.
With a background spanning healthcare, medical technology, and entrepreneurship, Fatima leads all aspects of the company's research and development programs, regulatory strategy, and business development activities.
Her deep domain expertise in biosensor science, medical device development, and healthcare systems drives iCGM Technologies' mission to make continuous, intelligent biometric monitoring accessible, accurate, and transformative for patients everywhere.
Regulatory Statement
Technologies described on this website are under research and development. Unless otherwise stated, they have not received FDA clearance or approval and are not available for commercial clinical use. Information is provided for educational and partnership purposes only.